Literature DB >> 15721485

Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN).

Seth D Norrholm1, Mahasweta Das, Gábor Légrádi.   

Abstract

Pituitary adenylate cyclase activating polypeptide (PACAP) has been implicated in the regulation of several autonomic and neuroendocrine functions. In the hypothalamic paraventricular nucleus (PVN), for example, PACAP-immunoreactive fibers densely innervate corticotropin-releasing hormone (CRH)-containing neurons in the medial parvocellular region, suggesting that PACAP acts to mediate stress responses. Therefore, we examined the behavioral effects of an intra-PVN PACAP injection (25 pmol) in combination with a mild stressor. PACAP or artificial cerebrospinal fluid (aCSF) was microinjected into the PVN (0.25 l) and then animals were restrained or placed in their home cage for 5 min. Exploratory activity (total distance traveled) and scored behaviors (face washing, body grooming, wet dog shakes, and rearing) were observed in a familiar open field for 10 min. In animals receiving aCSF, there were no behavioral differences between restrained and unrestrained groups. For the entire 10-min observation period, animals receiving PACAP, whether restrained or not, displayed elevated face washing and body grooming with decreased locomotor activity and rearing. Among PACAP-injected animals, restrained animals displayed increased body grooming compared to unrestrained animals during the first 2 min in the open field suggesting a summation of the effects of peptide injection and stressor. The observed elevation in grooming is consistent with previous studies reporting similar increases following electrical-, NMDA-, CRH-, or stressor-induced activation of the PVN. Thus, at the level of the PVN, PACAP may act as an excitatory neuropeptide and augment behavioral responses to stressors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15721485      PMCID: PMC1950325          DOI: 10.1016/j.regpep.2004.12.023

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  53 in total

1.  Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain.

Authors:  S Shioda; Y Shuto; A Somogyvari-Vigh; G Legradi; H Onda; D H Coy; S Nakajo; A Arimura
Journal:  Neurosci Res       Date:  1997-08       Impact factor: 3.304

2.  Nitric oxide synthase-containing magnocellular neurons of the rat hypothalamus synthesize oxytocin and vasopressin and express Fos following stress stimuli.

Authors:  S Hatakeyama; Y Kawai; T Ueyama; E Senba
Journal:  J Chem Neuroanat       Date:  1996-10       Impact factor: 3.052

3.  Perfusion of the paraventricular nucleus with pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide stimulates local release of norepinephrine and its metabolite: microdialysis study in freely moving rats.

Authors:  Q Huang; G Légrádi; A Arimura
Journal:  Ann N Y Acad Sci       Date:  1996-12-26       Impact factor: 5.691

4.  Hypovolemia upregulates the expression of neuronal nitric oxide synthase gene in the paraventricular and supraoptic nuclei of rats.

Authors:  Y Ueta; A Levy; S L Lightman; Y Hara; R Serino; M Nomura; I Shibuya; Y Hattori; H Yamashita
Journal:  Brain Res       Date:  1998-04-20       Impact factor: 3.252

5.  Anorectic and neurochemical effects of pituitary adenylate cyclase activating polypeptide in rats.

Authors:  W T Chance; H Thompson; I Thomas; J E Fischer
Journal:  Peptides       Date:  1995       Impact factor: 3.750

6.  PACAP type I receptor gene expression in the paraventricular and supraoptic nuclei of rats.

Authors:  M Nomura; Y Ueta; R Serino; N Kabashima; I Shibuya; H Yamashita
Journal:  Neuroreport       Date:  1996-12-20       Impact factor: 1.837

7.  Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus.

Authors:  V Grinevich; A Fournier; G Pelletier
Journal:  Brain Res       Date:  1997-10-31       Impact factor: 3.252

8.  Distribution of pituitary adenylate cyclase activating polypeptide (PACAP) immunoreactivity in the hypothalamus and extended amygdala of the rat.

Authors:  H D Piggins; J A Stamp; J Burns; B Rusak; K Semba
Journal:  J Comp Neurol       Date:  1996-12-09       Impact factor: 3.215

9.  Pituitary adenylate cyclase-activating polypeptide-nerve terminals densely innervate corticotropin-releasing hormone-neurons in the hypothalamic paraventricular nucleus of the rat.

Authors:  G Légrádi; J Hannibal; R M Lechan
Journal:  Neurosci Lett       Date:  1998-05-01       Impact factor: 3.046

10.  Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study.

Authors:  H Hashimoto; H Nogi; K Mori; H Ohishi; R Shigemoto; K Yamamoto; T Matsuda; N Mizuno; S Nagata; A Baba
Journal:  J Comp Neurol       Date:  1996-08-05       Impact factor: 3.215

View more
  26 in total

1.  CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP.

Authors:  Riccardo Dore; Attilio Iemolo; Karen L Smith; Xiaofan Wang; Pietro Cottone; Valentina Sabino
Journal:  Neuropsychopharmacology       Date:  2013-05-09       Impact factor: 7.853

Review 2.  Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies.

Authors:  Sayamwong E Hammack; Victor May
Journal:  Biol Psychiatry       Date:  2014-12-09       Impact factor: 13.382

3.  Impact of PACAP and PAC1 receptor deficiency on the neurochemical and behavioral effects of acute and chronic restraint stress in male C57BL/6 mice.

Authors:  Tomris Mustafa; Sunny Zhihong Jiang; Adrian M Eiden; Eberhard Weihe; Ian Thistlethwaite; Lee E Eiden
Journal:  Stress       Date:  2015-09-04       Impact factor: 3.493

Review 4.  PACAP: A regulator of mammalian reproductive function.

Authors:  Stephen J Winters; Joseph P Moore
Journal:  Mol Cell Endocrinol       Date:  2020-06-17       Impact factor: 4.102

5.  Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene.

Authors:  Anika Agarwal; Lisa M Halvorson; Gabor Legradi
Journal:  Brain Res Mol Brain Res       Date:  2005-07-29

Review 6.  Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Signaling and the Dark Side of Addiction.

Authors:  Olivia W Miles; Victor May; Sayamwong E Hammack
Journal:  J Mol Neurosci       Date:  2018-08-03       Impact factor: 3.444

7.  PACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress.

Authors:  Michael L Lehmann; Tomris Mustafa; Adrian M Eiden; Miles Herkenham; Lee E Eiden
Journal:  Psychoneuroendocrinology       Date:  2012-10-11       Impact factor: 4.905

8.  Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior.

Authors:  Sayamwong E Hammack; Joseph Cheung; Kimberly M Rhodes; Kristin C Schutz; William A Falls; Karen M Braas; Victor May
Journal:  Psychoneuroendocrinology       Date:  2009-01-31       Impact factor: 4.905

9.  Stress hormone synthesis in mouse hypothalamus and adrenal gland triggered by restraint is dependent on pituitary adenylate cyclase-activating polypeptide signaling.

Authors:  N Stroth; L E Eiden
Journal:  Neuroscience       Date:  2009-11-18       Impact factor: 3.590

10.  Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches.

Authors:  Claude Robert; Laurence Bourgeais; Charles-Daniel Arreto; Miguel Condes-Lara; Rodrigo Noseda; Thérèse Jay; Luis Villanueva
Journal:  J Neurosci       Date:  2013-05-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.